GB2286189A - Recombinant specific binding protein - Google Patents
Recombinant specific binding proteinInfo
- Publication number
- GB2286189A GB2286189A GB9507442A GB9507442A GB2286189A GB 2286189 A GB2286189 A GB 2286189A GB 9507442 A GB9507442 A GB 9507442A GB 9507442 A GB9507442 A GB 9507442A GB 2286189 A GB2286189 A GB 2286189A
- Authority
- GB
- United Kingdom
- Prior art keywords
- binding
- protein
- binding protein
- binding regions
- domains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
A specific binding protein having first and second binding regions, e.g. antibody Fv fragments, which specifically recognise and bind to target entities, said binding regions being contained at least in part on respectively first and second polypeptide chains, said chains additionally incorporating respectively first and second associating domains, e.g. antibody VH and VL domains, which are capable of binding to each other, causing the first and second polypeptide chains to combine, thereby providing a single protein incorporating the binding specificities of said first and second binding regions. The first and second binding regions may recognise different target entities, giving a bispecific binding protein. Preferably the associating domains are derived from a human protein (i.e. one which has been exposed to the human immune system), so that the protein is less likely to provoke the human immune system when administered therapeutically. The binding protein is suitably produced by recombinant DNA expression. <IMAGE>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9507442A GB2286189A (en) | 1992-10-15 | 1993-10-15 | Recombinant specific binding protein |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929221657A GB9221657D0 (en) | 1992-10-15 | 1992-10-15 | Recombinant bispecific antibodies |
PCT/GB1993/002133 WO1994009131A1 (en) | 1992-10-15 | 1993-10-15 | Recombinant specific binding protein |
GB9507442A GB2286189A (en) | 1992-10-15 | 1993-10-15 | Recombinant specific binding protein |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9507442D0 GB9507442D0 (en) | 1995-05-31 |
GB2286189A true GB2286189A (en) | 1995-08-09 |
Family
ID=26301800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9507442A Withdrawn GB2286189A (en) | 1992-10-15 | 1993-10-15 | Recombinant specific binding protein |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2286189A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002285A1 (en) * | 1981-12-21 | 1983-07-07 | Boston Biomed Res Inst | Bispecific antibody determinants |
EP0453082A1 (en) * | 1990-03-09 | 1991-10-23 | Hybritech Incorporated | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
WO1991019739A1 (en) * | 1990-06-11 | 1991-12-26 | Celltech Limited | Multivalent antigen-binding proteins |
-
1993
- 1993-10-15 GB GB9507442A patent/GB2286189A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983002285A1 (en) * | 1981-12-21 | 1983-07-07 | Boston Biomed Res Inst | Bispecific antibody determinants |
EP0453082A1 (en) * | 1990-03-09 | 1991-10-23 | Hybritech Incorporated | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
WO1991019739A1 (en) * | 1990-06-11 | 1991-12-26 | Celltech Limited | Multivalent antigen-binding proteins |
Non-Patent Citations (3)
Title |
---|
BIOCHEMISTRY Vol. 31, No. 6, 1988, pages 1579-1584 * |
BIOTECHNOLOGY Vol. 10, 1992, pages 163-167 * |
EMBO JOURNAL Vol. 10, No. 12, 1991, pages 3655-3659 * |
Also Published As
Publication number | Publication date |
---|---|
GB9507442D0 (en) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995016038A3 (en) | Humanized antibodies and uses thereof | |
Terry et al. | Subclasses of human γ2-globulin based on differences in the heavy polypeptide chains | |
NZ303375A (en) | Monoclonal antibodies specific for different epitopes of human gp39 and diagnostic and therapeutic methods using them | |
ZA891861B (en) | Monoclonal antibodies | |
CA2212750A1 (en) | Humanized antibodies against cd3 | |
AU735411C (en) | Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies | |
ATE384792T1 (en) | ANTIBODY VARIANTS WITH HIGHER BINDING AFFINITIES COMPARED TO PARENTAL ANTIBODIES | |
CA2128511A1 (en) | Monomeric and dimeric antibody-fragment fusion proteins | |
NZ508381A (en) | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) | |
DE69414870D1 (en) | ANTIBODY WITH CHANGED TARGET DIRECTION | |
EP1350799A3 (en) | Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor | |
FR2669338B1 (en) | ||
CA2068222A1 (en) | Monoclonal antibodies | |
AU3342397A (en) | Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use | |
DE69535855D1 (en) | CALCIUM BINDING RECOMBINANT ANTIBODIES TO PROTEIN C | |
ATE122894T1 (en) | USE AND COMPOSITION FOR IMPROVING THE TARGETING OF ANTIBODIES, ANTIBODY PARTS, AND CONJUGATES THEREOF. | |
GB9311454D0 (en) | Pharmaceutical compositions | |
WO1994004675A3 (en) | Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family | |
GB2286189A (en) | Recombinant specific binding protein | |
AU641736B2 (en) | Delivery of agents | |
AU5809290A (en) | Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application | |
WO1997004098A3 (en) | MODIFIED HUMAN CHORIONIC (β-hCG) PROTEINS AND THEIR MEDICAL USE | |
Mizutani et al. | Effector functions of a mouse IgG that lacks the entire CH1 domain. C1q binding and complement fixation in the absence of antigen. | |
WO1999019480A3 (en) | Human receptor proteins; related reagents and methods | |
GB2333295A (en) | Modified protein G and fragments thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |